1. Ashif Iqubal, et al.. COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention. In : Expert Review of Anti Infective Therapy (2021),19(9),pp1083–92. DOI: 10.1080/14787210.2021.1893692
2. Brit Long, et al., 2020. Cardiovascular complications in COVID-19. In : American Journal of Emergency Medicine (2020) 38, pp 1504 – 1507.
3. European Society of Cardiology, 2021. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID- 19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis. In: European Heart Journal (2022), 43, pp 1033–1058.
4. European Societ of Cardiology, 2021. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up. In : European Heart Journal (2022), 43, pp 1059–1103.
5. Farnaz F., et al., 2021. Cardiovascular complications of COVID-19. In : Journal of Clinical Investigation (2021), 6(13), pp 1 – 16.
6. Januar W.M, 2021. COVID-19 and Cardiovascular Complications: An Updated Review. In : Macedonian Journal of Medical Sciences,2021, 9(F), pp 712 – 719.
7. Jason P. B., 2022. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022. In : US Department of Health and Human Services/Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report (2022), 71 (14), pp517–523.
8. Pei Ni Jone, et al., 2022. SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association. In : Circulation (2022), 145, pp e1037 – e1052.
9. Weijie W., 2022. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks. In : The Lancet (2022), 53, pp 1 – 11.
10. Yan xie, 2022. Long-term cardiovascular outcomes of COVID-19. In : Nature Medicine (2022), 28, pp 583 – 590.
11. Yu Kang, et al., 2020. Cardiovascular manifestations and treatment considerations in COVID-19. In : Heart Journal (2020), 106, pp 1132 – 41.
12. Luetkens JA, Isaak A, Zimmer S et al. Diffuse myocardial inflammation in COVID-19 associated myocarditis detected by multiparametric cardiac magnetic resonance imaging. Circ Cardiovasc Imaging 2020;13:e010897.
13. Pillay J, Gaudet L, Wingert A, Bialy L, Mackie A S, Paterson D I et al. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review BMJ 2022; 378 :e069445 doi:10.1136/bmj-2021-069445
14. Louis DW, Saad M, Vijayakumar S, Ilyas S, Kokkirala A, et al. The Cardiovascular Manifestations of COVID-19. Cardiol Clin. 2022 Aug;40(3):277-285. doi: 10.1016/j.ccl.2022.03.001. Epub 2022 Mar 23. PMID: 35851451; PMCID: PMC8940573.
15. Jimenez D., Garcia-Sanchez A., Rali P., et al. Incidence of VTE and bleeding among hospitalized patients with Coronavirus disease 2019: a systematic review and meta-analysis. Chest. 2021;159(3):1182–1196.
16. Wang D, Hu B, Hu C, Zhu F, Liu X, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113. PMID: 32031570; PMCID: PMC7042881. → Raisi-Estabragh Z, Cooper J, Salih A, et alCardiovascular disease and mortality sequelae of COVID-19 in the UK BiobankHeart 2023;109:119-126.
17. Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020 Sep;17(9):1439-1444. doi: 10.1016/j.hrthm.2020.06.016. Epub 2020 Jun 22. PMID: 32585191; PMCID: PMC7307518.
18. Sawalha K, Abozenah M, Kadado AJ, Battisha A, Al-Akchar M, et al. Systematic Review of COVID-19 Related Myocarditis: Insights on Management and Outcome. Cardiovasc Revasc Med. 2021 Feb;23:107-113. doi: 10.1016/j.carrev.2020.08.028. Epub 2020 Aug 18. PMID: 32847728; PMCID: PMC7434380.
19. Manish B. Cardiovascular disease and COVID–19. In : Diabetes & Metabolic Syndrome : Clinical Research & Reviews (2020) 14, pp 247–50.
20. Voleti N, Reddy SP and Ssentongo P. Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis. Front. Cardiovasc. Med., 29 August 2022. Sec. Cardiovascular Epidemiology and Prevention. Volume 9 - 2022 | https://doi.org/10.3389/fcvm.2022.951314
21. Abutaleb, M.H.; Makeen, H.A.; Meraya, A.M.; Alqahtani, S.S.; Al-Mass, B.I.; et al. Risks of Cardiac Arrhythmia Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis. Vaccines 2023, 11, 112. https://doi.org/10.3390/vaccines11010112
22. Zuin M, Barco S, Giannakoulas G, Engelen MM, Hobohm L, Valerio L, Vandenbriele C, Verhamme P, Vanassche T, Konstantinides SV. Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis. J Thromb Thrombolysis. 2023 Jan 18:1–9. doi: 10.1007/s11239-022-02766-7. Epub ahead of print. PMID: 36652137; PMCID: PMC9845812.
Facebook 
Masuk dengan Email
